Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
William D. Carey, M.D. M.A.C.G., is currently the senior hepatologist in the Department of Gastroenterology at Cleveland Clinic in Cleveland, Ohio (former Director of the Hepatology (Liver) Center). Dr. Carey also serves as the Director for Cleveland Clinic's Center for Continuing Medical Education. Dr. Carey is board-certified in internal medicine and gastroenterology, and specializes in liver disease, including medical management of liver transplantation and endoscopy.
After graduating from Tufts University School of Medicine in Boston, Dr. Carey completed his residency in internal medicine and a fellowship in nephrology at Presbyterian Hospital in San Francisco. He also completed a fellowship in gastroenterology at the Mayo Clinic in Rochester, Minn.
He is Past-President of the American College of Gastroenterology, and is active in many other professional groups, including the American Association for the Study of Liver Diseases, the American Gastroenterological Association, the American College of Physicians, and the American Society for Gastrointestinal Endoscopy. He is a delegate to the American Medical Association.
biliary disorders, biliary tract disease, drug induced liver disease, end stage liver disease, Endoscopy, Eval and management of Hepatobiliary Malignancies, general hepatology, hepatitis B, hepatitis C and liver disease, hepatology, liver, liver and biliary tract disease, Liver Disease, Liver Transplantation, liver-biliary tract disease, non alcoholic fatty liver disease, viral hepatitis
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of Cleveland
Clinic's procedures. Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 7/28/2016 the review process regarding Dr. Carey's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.